Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing

[1]  Weiqi Wang,et al.  ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma , 2022, Translational oncology.

[2]  R. Flippot,et al.  Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma. , 2022, Bulletin du Cancer.

[3]  Yan-Long Liu,et al.  Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer , 2022, Frontiers in Immunology.

[4]  Er-Bao Bian,et al.  A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma , 2022, Frontiers in Oncology.

[5]  Fang Wang,et al.  An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma , 2022, Frontiers in Pharmacology.

[6]  Xianling Zhou,et al.  An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer , 2022, Frontiers in Genetics.

[7]  E. Gamazon,et al.  Integrative transcriptomic, evolutionary, and causal inference framework for region-level analysis: Application to COVID-19 , 2022, NPJ genomic medicine.

[8]  Liyang Zhang,et al.  The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment , 2022, Frontiers in Oncology.

[9]  L. Zou,et al.  FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Jian Zhang,et al.  5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma , 2022, Annals of translational medicine.

[11]  Jun Liu,et al.  Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma , 2022, Frontiers in Cell and Developmental Biology.

[12]  F. Massari,et al.  Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors. , 2022, European urology focus.

[13]  F. Safari,et al.  The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signaling , 2022, Medical Oncology.

[14]  I. Rzeszutek,et al.  Deficiency of TRDMT1 impairs exogenous RNA-based response and promotes retrotransposon activity during long-term culture of osteosarcoma cells. , 2022, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  Bairong Shen,et al.  CRPMKB: a knowledge base of cancer risk prediction models for systematic comparison and personalized applications , 2021, Bioinform..

[16]  F. Massari,et al.  Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma , 2021, Targeted Oncology.

[17]  D. Ye,et al.  Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma , 2021, Frontiers in Cell and Developmental Biology.

[18]  Jinhong Chen,et al.  m6A target microRNAs in serum for cancer detection , 2021, Molecular cancer.

[19]  Jingjie Zhao,et al.  The Identification of a Tumor Infiltration CD8+ T-Cell Gene Signature That Can Potentially Improve the Prognosis and Prediction of Immunization Responses in Papillary Renal Cell Carcinoma , 2021, Frontiers in Oncology.

[20]  Debo Chen,et al.  Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer , 2021, Frontiers in Genetics.

[21]  J. Salleron,et al.  Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors , 2021, Frontiers in Immunology.

[22]  R. Satcher,et al.  All bone metastases are not created equal: Revisiting treatment resistance in renal cell carcinoma , 2021, Journal of bone oncology.

[23]  D. Lin,et al.  NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization , 2021, Oncogene.

[24]  Y. Qiu,et al.  Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19 , 2021, Theranostics.

[25]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[26]  M. Wnuk,et al.  The lack of functional DNMT2/TRDMT1 gene modulates cancer cell responses during drug-induced senescence , 2021, Aging.

[27]  Q. Liao,et al.  Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer , 2021, Frontiers in Oncology.

[28]  Yadi Liu,et al.  N6‐methyladenosine Steers RNA Metabolism and Regulation in Cancer , 2021, Cancer communications.

[29]  Lei Xi,et al.  Differential Mutation Detection Capability Through Capture-Based Targeted Sequencing in Plasma Samples in Hepatocellular Carcinoma , 2021, Frontiers in Oncology.

[30]  P. Marchetti,et al.  Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice , 2021, Frontiers in Oncology.

[31]  R. Montironi,et al.  Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials. , 2021, European urology focus.

[32]  Zhe Zhang,et al.  A Weighted Gene Co-Expression Network Analysis–Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer , 2021, Frontiers in Oncology.

[33]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[34]  L. Lan,et al.  Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response , 2021, NAR cancer.

[35]  Yuki Kataoka,et al.  Integrated model for COVID-19 diagnosis based on computed tomography artificial intelligence, and clinical features: a multicenter cohort study , 2021, Annals of translational medicine.

[36]  Hongtu Zhang,et al.  Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review , 2020, Translational andrology and urology.

[37]  Zheng Wang,et al.  Open resource of clinical data from patients with pneumonia for the prediction of COVID-19 outcomes via deep learning , 2020, Nature Biomedical Engineering.

[38]  C. Drake,et al.  Kidney Cancer: An Overview of Current Therapeutic Approaches. , 2020, The Urologic clinics of North America.

[39]  Jie Jin,et al.  The emerging roles of N6-methyladenosine RNA methylation in human cancers , 2020, Biomarker Research.

[40]  Yuting He,et al.  Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues , 2020, Journal of Translational Medicine.

[41]  A. Duttaroy,et al.  Curcumin stimulates angiogenesis through VEGF and expression of HLA‐G in first‐trimester human placental trophoblasts , 2020, Cell Biology International.

[42]  Martha E. Zeeman,et al.  Human chimeric antigen receptor macrophages for cancer immunotherapy , 2020, Nature Biotechnology.

[43]  K. Suszták,et al.  Dnmt3a and Dnmt3b-Decommissioned Fetal Enhancers are Linked to Kidney Disease. , 2020, Journal of the American Society of Nephrology : JASN.

[44]  G. Zeng,et al.  Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments , 2020, Cancer Cell International.

[45]  Qiqi Cui,et al.  The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis , 2019, Journal of Experimental & Clinical Cancer Research.

[46]  Dan Xie,et al.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.

[47]  Xiaorong Yang,et al.  A comparison of the prognosis of papillary and clear cell renal cell carcinoma , 2019, Medicine.

[48]  R. Treisman,et al.  RPEL-family rhoGAPs link Rac/Cdc42 GTP loading to G-actin availability , 2019, Nature Cell Biology.

[49]  Alexa B. R. McIntyre,et al.  Limits in the detection of m6A changes using MeRIP/m6A-seq , 2019, Scientific Reports.

[50]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[51]  R. Harris,et al.  Renal Medullary Interstitial COX-2 (Cyclooxygenase-2) Is Essential in Preventing Salt-Sensitive Hypertension and Maintaining Renal Inner Medulla/Papilla Structural Integrity , 2018, Hypertension.

[52]  Yassen Assenov,et al.  Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.

[53]  S. Bortoluzzi,et al.  Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease , 2018, International journal of cancer.

[54]  Jie Gu,et al.  Novel insights into biomarkers associated with renal cell carcinoma , 2018, Oncology letters.

[55]  T. Choueiri,et al.  Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial. , 2018, The Lancet. Oncology.

[56]  M. Gorospe,et al.  NSUN2‐Mediated m5C Methylation and METTL3/METTL14‐Mediated m6A Methylation Cooperatively Enhance p21 Translation , 2017, Journal of cellular biochemistry.

[57]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[58]  Chuan He,et al.  Post-transcriptional gene regulation by mRNA modifications , 2016, Nature Reviews Molecular Cell Biology.

[59]  Aaron T. L. Lun,et al.  From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline , 2016, F1000Research.

[60]  Christopher E. Mason,et al.  Single-nucleotide resolution mapping of m6A and m6Am throughout the transcriptome , 2015, Nature Methods.

[61]  B. Yin,et al.  Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma. , 2014, International journal of clinical and experimental pathology.

[62]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[63]  Jean-François Dartigues,et al.  Estimating and comparing time‐dependent areas under receiver operating characteristic curves for censored event times with competing risks , 2013, Statistics in medicine.

[64]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[65]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[66]  M. Gorospe,et al.  NSUN 2-mediated m 5 C methylation and METTL 3 / METTL 14-mediated m 6 A methylation cooperatively enhance p 21 translation † Running Title : NSUN 2 and METTL 3 / METTL 14 regulate p 21 translation , 2017 .

[67]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[68]  Xue-Ru Wu.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall’s plaques , 2014, Urolithiasis.